CN Stock MarketDetailed Quotes

600671 Hangzhou Tianmushan Pharmaceutical Enterprise

Watchlist
  • 9.36
  • -0.38-3.90%
Market Closed Dec 13 15:00 CST
1.14BMarket Cap-78.66P/E (TTM)

Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Tianmushan Pharmaceutical Enterprise Earnings Estimates

Revenue

EPS

EBIT

No Data

Hangzhou Tianmushan Pharmaceutical Enterprise Earnings Reports

  • Hangzhou Tianmushan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 29 12:00 ET

  • Hangzhou Tianmushan Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    Aug 29 12:00 ET

  • Summary of the 2024 semi-annual report of Hangzhou Tianmusan Pharmaceutical Co., Ltd.

    Aug 29 12:00 ET

  • Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd. 2024 semi-annual performance forecast.

    Jul 9 12:00 ET

    • Read more

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme ST concept
    ST concept
    Intraday-1.52%
    State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday-1.75%